Alignment Healthcare grants 23,441 RSUs

Mansour Adnan R. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Mansour Adnan R. reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare, Inc. reported that Chief Digital Officer Adnan R. Mansour received an equity grant in the form of 23,441 restricted stock units (RSUs), each representing one share of common stock at no purchase price.

The RSUs will vest in approximately equal installments on February 4, 2027, 2028 and 2029, as long as Mansour continues to serve the company on each vesting date. This award increases his directly held equity stake and further links his compensation to the company’s long-term stock performance.

Insider Trade Summary

Grant/Award: 23,441 shares

Grant/Award 1 txn

Insider Mansour Adnan R.

Role Chief Digital Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	23,441	$0.00	$0.00

Holdings After Transaction: Common Stock — 23,441 shares (Direct)

Footnotes (1)

1. F1. Represents 23,441 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest in approximately equal installments on each of February 4, 2027, 2028 and 2029, subject to the reporting person's continued service to the Company on the applicable vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Alignment Healthcare (ALHC) disclose in this Form 4?

Alignment Healthcare disclosed an equity award to its Chief Digital Officer, Adnan R. Mansour, of 23,441 restricted stock units. Each RSU represents one share of common stock, granted at no purchase price, increasing his directly held equity-based compensation stake in the company.

How many shares are covered by Adnan R. Mansour’s new RSU grant at ALHC?

The grant covers 23,441 restricted stock units for Adnan R. Mansour. Each RSU corresponds to one share of Alignment Healthcare common stock, so the award represents potential delivery of 23,441 shares if and when the units vest under the stated conditions.

When do the newly granted Alignment Healthcare RSUs vest for the Chief Digital Officer?

The 23,441 restricted stock units vest in three approximately equal installments. Vesting occurs on February 4, 2027, February 4, 2028 and February 4, 2029, provided Adnan R. Mansour continues his service with Alignment Healthcare on each respective vesting date.

Did Adnan R. Mansour pay anything for the 23,441 Alignment Healthcare RSUs?

No cash payment was required for this award, as indicated by the reported price of $0.00 per share. The RSUs are part of his equity compensation, delivering shares over time if vesting and continued service conditions are satisfied under the company’s plan.

What is Adnan R. Mansour’s share balance in Alignment Healthcare after this Form 4 transaction?

Following the reported grant, Adnan R. Mansour holds 23,441 shares or share-equivalent RSUs directly. This total reflects the newly awarded restricted stock units, which convert into common shares only as they vest over the scheduled dates, assuming continued service.

What role does the reporting person hold at Alignment Healthcare (ALHC)?

The reporting person, Adnan R. Mansour, serves as Alignment Healthcare’s Chief Digital Officer. The Form 4 shows an equity compensation grant in that capacity, aligning his interests with shareholders through time-based vesting of restricted stock units tied to the company’s common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 05:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mansour Adnan R.

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY DRIVE

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Digital Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		A		23,441(1)	A	$0	23,441	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 23,441 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest in approximately equal installments on each of February 4, 2027, 2028 and 2029, subject to the reporting person's continued service to the Company on the applicable vesting date.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Adnan R. Mansour	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.